SCD Stem Cell Mobilization and Apheresis Using Motixafortide

NCT06442761 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DRUG: Motixafortide

Sponsor

St. Jude Children's Research Hospital

Collaborators

[object Object]